Clinical Observation of Moxifloxacin Combined with Cefoperazone Sodium And Sulbactam Sodium in Treatment of Severe Pneumonia of the Elderly
Objective To explore clinical observation of moxifloxacin combined with cefoperazone sodium and sulbactam sodium in treatment of severe pneumonia of the elderly.Methods The paper chose 70 elderly patients with severe pneumonia admitted to our hospital from January 2022 to December 2022,and divided them into two groups.Control group was treated with cefoperazone sodium and sulbactam sodium,while study group with moxifloxacin combined with cefoperazone sodium and sulbactam sodium.Results Curative effect of study group was better and incidence of adverse reactions was lower than control group,(P<0.05).Level of inflammatory factors in study group was lower than control group(P<0.05).Lung function indicators in study group were better than control group(P<0.05).Conclusion Moxifloxacin combined with cefoperazone sodium and sulbactam sodium can achieve significant application effect in treatment of severe pneumonia of the elderly,can improve clinical symptoms and lung function indicators of patients effectively,eliminate inflammatory reactions in the body,and reduce incidence of adverse reactions,which is worth promoting.
MoxifloxacinCefoperazone sodium and sulbactam sodiumCombination therapySevere pneumonia of the elderlyClinical effectPulmonary function
万方数据
维普
